Nadda urges industry, academia collaboration to build better healthcare at Healthcare Summit at IIMA Read more
Zydus receives USFDA approval to conduct Phase II(b) clinical trial for Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with ALS Read more
Zydus signs agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR (Sitagliptin | Sitagliptin and Metformin Hydrochloride) to its template formulary Read more
Indian pharma companies focus on innovative research in foreign countries through dedicated entities Read more
Zydus, ICMR initiate Phase 2 clinical trial of Desidustat in patients with Sickle Cell Disease Read more
Zydus gains final USFDA approval for Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg Read more